SEC Form 4 · accession 0001144204-15-055300
IMMUNE PHARMACEUTICALS INC · IMNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Kazado
Director
Period of report
Sep 14, 2015
Accepted (ET)
Sep 16, 2015 · 5:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001208261
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 14, 2015 | P | 50,000 | $1.4696 | A | 90,623 | D |
Table II — derivative securities
No Table II lines on this filing.